For demo purposes only – Not for redistribution
First-line Immunotherapy for Metastatic Gastroesophageal Cancers
Using a case-based approach, this course explores recent research findings on immunotherapy for metastatic gastroesophageal cancer. This course includes a special focus on biomarker testing integration into the treatment of gastroesophageal cancers.
Learning Objectives
Upon participation in this activity, learners will be better able to:
- Discuss recent evidence and patient and disease factors that will influence decision-making regarding first-line immunotherapy for patients with metastatic gastroesophageal cancer.
Faculty
Katherine Bever, MD
Johns Hopkins University Baltimore, MD
